Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
Top Cited Papers
- 1 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (1), 169-176
- https://doi.org/10.1038/s41375-020-0797-x
Abstract
Richter transformation (RT) is defined as development of aggressive lymphoma in patients (pts) with CLL. The incidence rates of RT among pts with CLL range from 2 to 10%. The aim of this analysis is to report the frequency, characteristics and outcomes of pts with RT enrolled in trials of the GCLLSG. A total of 2975 pts with advanced CLL were reviewed for incidence of RT. Clinical, laboratory, and genetic data were pooled. Time-to-event data, starting from time of CLL diagnosis, of first-line therapy or of RT diagnosis, were analyzed by Kaplan-Meier methodology. One hundred and three pts developed RT (3%): 95 pts diffuse large B-cell lymphoma (92%) and eight pts Hodgkin lymphoma (8%). Median observation time was 53 months (interquartile range 38.1-69.5). Median OS from initial CLL diagnosis for pts without RT was 167 months vs 71 months for pts with RT (HR 2.64, CI 2.09-3.33). Median OS after diagnosis of RT was 9 months. Forty-seven pts (46%) received CHOP-like regimens for RT treatment. Three pts subsequently underwent allogeneic and two pts autologous stem cell transplantation. Our findings show that within a large cohort of GCLLSG trial participants, 3% of the pts developed RT after receiving first-line chemo- or chemoimmunotherapy. This dataset confirms the ongoing poor prognosis and high mortality associated with RT.This publication has 46 references indexed in Scilit:
- Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapyHaematologica, 2019
- PD‐1 is highly expressed by neoplastic B‐cells in Richter transformationBritish Journal of Haematology, 2018
- PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT)The American Journal of Surgical Pathology, 2018
- Biology and treatment of Richter syndromeBlood, 2018
- Diagnosis of Richter transformation in chronic lymphocytic leukemia: histology tips the scalesAnnals of Hematology, 2018
- Diffuse large B‐cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patientsBritish Journal of Haematology, 2013
- Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literatureBritish Journal of Haematology, 2011
- The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformationBlood, 2011
- IgVH Mutational Status and Clonality Analysis of Richter's TransformationThe American Journal of Surgical Pathology, 2007
- Hodgkin's Disease Variant of Richter's Syndrome:Report of Eight CasesAmerican Journal of Clinical Pathology, 1990